Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 11 (November)

1. A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500).
   J Thorac Oncol, 2(11): 1036-41. [Abstract] [Full-text]
2. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group.
   Pediatrics, 120(5): e1229-36. [Abstract] [Full-text]
3. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.
   Am J Obstet Gynecol, 197(5): 503.e1-6. [Abstract] [Full-text]
4. Surgical oncology in the community hospital: can it be done safely?
   South Med J, 100(11): 1091-4. [Abstract] [Full-text]
5. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
   Am J Hematol, 82(12): 1056-62. [Abstract] [Full-text]
6. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.
   Mutagenesis, 22(6): 395-401. [Abstract] [Full-text]
7. Laser-driven proton oncology--a unique new cancer therapy?
   Br J Radiol, 80(959): 855-8. [Abstract] [Full-text]
8. Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experience.
   Cancer, 110(10): 2331-8. [Abstract] [Full-text]
9. Evaluation and art therapy treatment of the burnout syndrome in oncology units.
   Psychooncology. [Abstract] [Full-text]
10. Patient-reported outcomes and the evolution of adverse event reporting in oncology.
    J Clin Oncol, 25(32): 5121-7. [Abstract] [Full-text]
11. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
    J Clin Oncol, 25(32): 5087-93. [Abstract] [Full-text]
12. Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.
    Lung Cancer, 58(3): 355-61. [Abstract] [Full-text]
13. Determinants and patient-reported long-term outcomes of physician empathy in oncology: A structural equation modelling approach.
    Patient Educ Couns, 69(1): 63-75. [Abstract] [Full-text]
14. Young patients', parents', and survivors' communication preferences in paediatric oncology: results of online focus groups.
    BMC Pediatr, 7(1): 35. [Abstract] [Full-text]
15. Follow-up strategies in gynecological oncology: searching appropriateness.
    Int J Gynecol Cancer, 17(6): 1186-93. [Abstract] [Full-text]
16. Interventional radiology and the care of the pediatric oncology patient.
    Surg Oncol, 16(3): 229-33. [Abstract] [Full-text]
17. Pediatric surgical oncology: Management of rhabdomyosarcoma.
    Surg Oncol, 16(3): 173-85. [Abstract] [Full-text]
18. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Ann Surg Oncol, 14(12): 3328-34. [Abstract] [Full-text]
19. Trends in the use and role of biomarkers in phase I oncology trials.
    Clin Cancer Res, 13(22): 6719-26. [Abstract] [Full-text]
20. Effect of the clinical support nurse role on work-related stress for nurses on an inpatient pediatric oncology unit.
    J Pediatr Oncol Nurs, 24(6): 340-9. [Abstract] [Full-text]
21. Obstacles to transcultural caring relationships: experiences of health care staff in pediatric oncology.
    J Pediatr Oncol Nurs, 24(6): 314-28. [Abstract] [Full-text]
22. Metastatic spinal cord compression as an oncology emergency getting our act together.
    Int J Qual Health Care, 19(6): 377-81. [Abstract] [Full-text]
23. Monoclonal outbreak of catheter-related bacteraemia by Ralstonia mannitolilytica on two haemato-oncology wards.
    J Infect, 55(6): 539-44. [Abstract] [Full-text]
24. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
    J Clin Oncol, 25(33): 5287-312. [Abstract] [Full-text]
25. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
    J Clin Oncol, 25(33): 5313-8. [Abstract] [Full-text]
26. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 25(33): 5165-71. [Abstract] [Full-text]
27. Methodologic issues in exercise intervention research in oncology.
    Semin Oncol Nurs, 23(4): 297-304. [Abstract] [Full-text]
28. The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views.
    Psychooncology. [Abstract] [Full-text]
29. Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.
    Int J Radiat Oncol Biol Phys, 69(5): 1572-8. [Abstract] [Full-text]
30. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
    Pediatr Blood Cancer, 50(1): 33-6. [Abstract] [Full-text]
31. An exploratory, interview study of oncology patients' and health-care staff experiences of discussing resuscitation.
    Psychooncology, 16(11): 985-93. [Abstract] [Full-text]
32. Concerns about infertility risks among pediatric oncology patients and their parents.
    Pediatr Blood Cancer, 50(1): 85-9. [Abstract] [Full-text]
33. Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study.
    Cancer, 110(11): 2568-75. [Abstract] [Full-text]
34. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
    Cancer, 110(11): 2535-41. [Abstract] [Full-text]
35. Readmission to intensive care unit after initial recovery from major thoracic oncology surgery.
    Ann Thorac Surg, 84(6): 1838-46; discussion 1838-46. [Abstract] [Full-text]
36. Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice.
    Psychooncology, 16(12): 1069-79. [Abstract] [Full-text]
37. Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.
    Anticancer Drugs, 19(1): 91-6. [Abstract] [Full-text]
38. Overview of targeted therapies in Oncology.
    J Oncol Pharm Pract, 13(4): 199-205. [Abstract] [Full-text]
39. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    J Clin Oncol, 25(34): 5506-18. [Abstract] [Full-text]
40. Medicinal cannabis in oncology.
    Eur J Cancer, 43(18): 2638-44. [Abstract] [Full-text]
41. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
    J Clin Oncol, 25(34): 5458-64. [Abstract] [Full-text]
42. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
    J Clin Oncol, 25(34): 5490-505. [Abstract] [Full-text]
43. Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.
    J Clin Oncol, 25(34): 5418-25. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.